| |
 Karen
Farris, Ph.D.
Professor
S 512 PHAR I
Iowa City IA 52242-1112
319.384.4516 (office); 319.353.5646 (fax)
Email: karen-farris@uiowa.edu
| EDUCATION |
|
Doctor of Philosophy, Pharmacy Administration,
The University of Michigan, Ann Arbor, MI, 1993. |
|
Master of Public Administration, concentration
in Health Services Administration, University of Memphis,
Memphis, TN, 1989. |
|
Bachelor of Science, Pharmacy, University
of Tennessee - Memphis, TN, 1986. |
|
Pre-pharmacy, Freed-Hardeman University,
Henderson, TN, 1981-1983. |
| Professional
Experience |
|
Professor, Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, IA, 2008-present. |
|
Assistant Head
for Post-Professional Education, Division of Clinical & Administrative
Pharmacy, College of Pharmacy, University of Iowa,
Iowa City, IA, 2005-present. |
|
Associate Professor, Community
and Behavioral Health, College of Public Health, University
of Iowa, Iowa City, IA (secondary appointment), 2003-present. |
|
Associate
Professor, Clinical and Administrative Pharmacy, College
of Pharmacy, University of Iowa, Iowa City, IA (with
tenure), 2000-2008. |
|
Adjunct Professor, Faculty
of Pharmacy and Pharmaceutical Sciences, University
of Alberta, Edmonton, AB Canada, 2000-present. |
|
Associate Professor,
Faculty of Pharmacy and Pharmaceutical Sciences, University
of Alberta, Edmonton, AB Canada (with tenure), 1999-2000. |
|
Adjunct
Professor, Department of Public Health Sciences, Faculty
of Medicine and Oral Health Sciences, University of
Alberta, 1998-2000. |
|
Faculty Associate, Centre for
Health Promotion Studies, University of Alberta, Edmonton,
AB Canada, 1996-present. |
|
Lecturer,
Department of Public Health Sciences, Faculty of Medicine,
University of
Alberta, Edmonton, AB Canada, 1995-1997. |
|
Sessional,
Department of Public Health Sciences, Faculty of Medicine,
University of
Alberta, Edmonton, AB Canada, 1995. |
|
Assistant Professor,
Faculty of Pharmacy and Pharmaceutical Sciences, University
of Alberta, Edmonton, AB Canada, 1993-1999. |
|
Research
Assistant, M-Care Drug Utilization Review Program,
College of Pharmacy,
The University of Michigan, Ann Arbor, MI, 1991-1993. |
|
Part-time
pharmacist. Lucky Drugs #2, Ann Arbor, MI. Community
pharmacy practice with emphasis on patient counseling, 1991-1992. |
|
Part-time
pharmacist. PharmaThera, Inc., Memphis, TN. A
home health care provider of TPN, growth hormone, pain
management and chemotherapy medications to patients
in the entire Mid-South area, 1988-1989. |
|
Staff
pharmacist. St. Joseph Hospital, Memphis, TN, 1986-1987. |
|
Pharmacy
internships (3 months). Mt. Edgecumbe Indian
Health Service Hospital,
Sitka, AK, 1986. |
| Honors and Awards |
|
University of Iowa College of Pharmacy – P3 Class Teacher of the Year, 2006 |
|
Fellow, American Pharmacists
Association, 2006. |
|
American Association of Colleges of
Pharmacy Lyman Award, for, Freml JM, Farris KB, Fang
G, Currie J. Iowa Priority's Brown Bag Medication
Reviews: A Comparison of Pharmacy Students and
Pharmacists. Am J Pharm Educ [serial
online]. 2004;68(2) Article 50. |
|
American Foundation
for Pharmaceutical Education Fellow, 1991-1993. |
|
Phi Lambda Sigma
Pharmaceutical Leadership Society, 1986. |
|
IMHOTEP Society, 1986. |
|
Rho Chi Pharmaceutical
Honor Society, 1984. |
|
| Organizational
Memberships |
|
Iowa
Pharmacy Association, 2000-present. |
|
Canadian
Pharmacists Association, 1994-2000. |
|
Association
of Faculties of Pharmacy of Canada (AFPC), 1993-2000. |
|
Tennessee
Pharmacists Association, 1989-2005. |
|
American
Association of Colleges of Pharmacy (AACP), 1989-present. |
|
American
Pharmaceutical Association (APhA), 1989-present. |
| Select Scholarly
Activities |
|
John M. Brooks, Donald G. Klepser, Julie G. Urmie, Karen B. Farris, William R. Doucette. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services. Journal of Health and Human Services Administration 2007 30(1):4-27. |
|
Yifei Liu, William R. Doucette, Farris K. Perceived difficulty and self-efficacy in the factor structure of perceived behavioral control to seek drug information from physicians and pharmacists. Research Soc Admin Pharm 2007;3(2):145-59. |
|
Julie M. Ganther-Urmie, Farris K, William R. Doucette, John M. Brooks. Iowa Medicare beneficiaries’ satisfaction and experiences with a prescription drug discount card and preferred drug list. J Am Pharm Assoc 2006;46:715-22. |
|
Kathleen E. Herbert, Julie M. Urmie, Brand A. Newland*, Farris K. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Research Soc Admin Pharm 2006;2:2990-314. |
|
Elizabeth J John, Theresa Vavra, Farris K, Jay Currie, William Doucette, Brenna Button-Neumann^, Matt Osterhaus, Patty Kumbera, Tom Halterman, Tammy Bullock. Workplace-Based Cardiovascular Risk Management by Community Pharmacists: Impact on Blood Pressure and Lipid Level. Pharmacother 2006;26:1511-7. |
|
Elizabeth J John, Theresa Vavra, Farris K, Jay Currie, William Doucette, Brenna Button-Neumann, Matt Osterhaus, Patty Kumbera, Tom Halterman, Tammy Bullock. Workplace-Based Cardiovascular Risk Management by Community Pharmacists: Impact on Blood Pressure and Lipid Level. Pharmacother 2006;26:1511-7. |
|
Jessica Purcell, Farris K, Mary Aquilino. Brief smoking cessation intervention in community pharmacies: Does it work? J Am Pharm Assoc 2006;46:616-8. |
|
Dale B. Christensen, Farris K. Pharmaceutical Care in Community Pharmacies: Practice and Research in the United States. Ann Pharmacother 2006;40:1400-6. |
|
Sheri L. Maddigan, David H. Feeny, Sumit R. Majumdar,
Farris K, Jeffrey A. Johnson. Understanding
the Determinants of Health for People with Type 2
Diabetes. Am J Pub Health 2006;96:1649-55.. |
|
Lisa Hickey, Farris K, N. Andrew Petersen,
Mary Aquilino, Predicting Tobacco Sales in Community
Pharmacies using Population Demographics and Pharmacy
Type. J Am Pharm Assoc 2006;46:385-90. |
|
Sheri L. Maddigan, David H. Feeny, Sumit R. Majumdar,Farris K, Jeffrey A. Johnson. Construct Validity
of the Health Utilities Index Mark 3 in Type 2 Diabetes:
Evidence from a Nationally Representative Sample of
Canadians. Submitted to Working Paper Series at Institute
of Health Economics, 2005. |
|
Sherry L. Maddigan, David H. Feeny, Sumit R. Majumdar,
Farris K, Jeffrey A. Johnson. Understanding
Determinants of Health in Type 2 Diabetes. Institute of
Health Economics Working Paper, 2005:
WP 05-01. |
|
Farris K. (Invited Peer-Reviewed Editorial) Relationships & responsibilities
are critical to team care in medication management. Research
in Social & Administrative Pharmacy, 2005;1:
369-74. |
|
Justin Wilson, Matt Osterhaus, Farris K, William
Doucette, Jay Currie, Tammy Bullock, Patty Kumbera.
A financial analysis of a cardiovascular wellness
program in a self-insured company from the pharmaceutical
care provider’s perspective. J Am Pharm
Assoc 2005;45:588-92. |
|
Yifei Liu, William R. Doucette, Farris K,
Dhananjay Nayakankuppam, Drug information seeking
intention and behavior after exposure to direct-to-consumer
advertisement (DTCA) of prescription drugs. Research
in Social & Administrative Pharmacy, 2005;1:251-269. |
|
Farris K, Fernandez-Llimos F, Benrimoj SI. Pharmaceutical
care in community pharmacies: practice and research
from around the world. Annals Pharmacother 2005;39:1539-41
(DOI 10.1345/aph.1G049). |
|
Danielle L. Ficke, Farris K. Use of the
Trans-theoretical model in the medication use process. Annals
Pharmacother 2005:39:1325-30. (DOI 10.1345/aph.1G122). |
|
Simpson SH, Johnson JA, Farris K, Lau TTY, Majumdar
SR, Cave A, Tsuyuki RT, for the SCRIP Investigators.
Physician perceptions of enhanced community pharmacist
care in cholesterol management: a survey of physicians
contacted during the Study of Cardiovascular Risk
Intervention by Pharmacists (SCRIP). Can Pharm
J 2005;138(4):33-39. |
|
David Feeny,Farris K, Isabelle Côté,
Jeffrey A. Johnson, Ross T. Tsuyuki, Ken Eng. The
construct validity of the RAND-12 and health utilities
index mark 2 and mark 3 in High-risk primary care
patients. J Clin Epidemiol 2005;58:138-41. |
|
Farris K, Julie M. Urmie, Gang Fang, William
R. Doucette, John M. Brooks, Donald Klepser, David
Fries, Carole Kuhle. Population-based medication
reviews: A descriptive analysis of the medication
issues identified in a Medicare not-for-profit prescription
discount program. Annals Pharmacother 2004;38:1823-9. |
|
Alan J. Zillich, Mary L. Aquilino, Farris K.
Knowledge and attitudes about smoking cessation among
pharmacy technicians. J Am Pharm Assoc 2004;44:578-82. |
|
Farris K, Isabelle Cote, David Feeny, Jeffrey
A. Johnson, Ross T. Tsuyuki, Sandra Brilliant, Sherry
Dieleman. Using multi-disciplinary teams to enhance
primary health care: a demonstration project. Canadian
Family Physician 2004;50:998-1003. |
|
Jared M. Freml, Farris K, Gang Fang,
Jay Currie. Recommendations from Iowa Priority’s
Brown Bag Medication Reviews: A comparison of student
pharmacists and pharmacists. Am J Pharm
Educ 2004;68 (2): article 50. |
|
Sherry L. Dieleman,Farris K, David Feeny,
Jeffrey A. Johnson, Ross T. Tsuyuki, Sandra Brilliant.
Primary Health Care Teams: Team Members' Perceptions
of the Collaborative Process. J Interprofessional
Care 2004;18:75-8. |
|
Farris K, Ann Marie McCarthy, Michael W.
Kelly, Daniel Clay. Issues related to medication
administration in midwestern schools. Journal
of School Health 2003;73:331-7. |
|
Isabelle Côté, Farris K, David
Feeny. Is compliance with drug treatment correlated
with health-related quality of life? Quality
of Life Research 2003;12:621-33. |
|
Sheri L. Maddigan, Farris K, Nora Keating,
Cheryl A. Wiens, Jeffrey A. Johnson. Predictors of
older adults' capacity for medication management
in a self-medication program: A retrospective chart
review. Journal of Aging and Health 2003;15(2):332-352. |
|
Mary L. Aquilino, Farris K, Alan J. Zillich,
John Lowe. Smoking cessation services in Iowa community
pharmacies. Pharmacotherapy 2003;23:666-673. |
|
Farris K, Elizabeth A. Chrischilles, John
M. Brooks, Bernard A. Sorofman, William R. Doucette.
(Invited Commentary). Pharmacist care programme increased
patient satisfaction, but had little clinical benefit
for people with asthma and chronic obstructive pulmonary
disease. Evidenced-based Healthcare 2003;7:33-35. |
|
Farris K, Michael W. Kelly, Jennifer Tryon.
Clock drawing and medication complexity index as
indicators of medication management capacity: a pilot
study. J Am Pharm Assoc 2003;43:78-80. |
|
Rosemin Kassam, Linda Gore Martin, Farris K.
Reliability of the medication appropriateness index
(MAI) in the community pharmacy setting. Annals
of Pharmacotherapy 2003;37:40-6. |
|
Isabelle Côté, Farris K, David
Feeny, Jeffrey A. Johnson, Ross T. Tsuyuki, Sherry
L. Dieleman, Sandra Brilliant, Ross Bayne, Leslie
Gardner, David Moores, Marj Sandilands. Using multidisciplinary
teams to improve primary care: quality of medication
use in the community. Working Paper 02-01. Institute
of Health Economics, 2002. |
|
Farris K, Patty Kumbera, Tom Halterman,
Gang Fang. Outcomes-based Pharmacist Reimbursement: Reimbursing
pharmacists for cognitive services. J Manage
Care Pharm 2002;8:383-93. |
|
Scot Simpson, Jeffrey A. Johnson J, Farris K,
Ross T. Tsuyuki. Development and validation of a
survey to assess barriers to drug use in patients
with chronic heart failure. Pharmacotherapy 2002;22:1163-72. |
|
Alan J. Zillich, Melody Ryan, Aimee Adams, Bryan
Yeager, Farris K. Effectiveness of a pharmacist-based
smoking cessation program and the impact on quality
of life. Pharmacother 2002;6:759-65. |
|
Ross T. Tsuyuki, Jeffrey A. Johnson, Koon K. Teo,
Scot H. Simpson, Margaret L. Ackman, Rosemarie S.
Biggs, Andrew J. Cave, Wei-ching Chang, Vlad Dzavil,
Farris K, Donna Galvin, William Semchuk, Jeff
G. Taylor for the SCRIP Investigators. A randomized
trial of the effect of community pharmacist intervention
on cholesterol risk management: The Study of Cardiovascular
Risk Intervention by Pharmacists (SCRIP). Arch
Intern Med 2002;162:1149-55. |
|
Lisa M. Schapansky, Jeffrey A. Johnson, Farris K, Ross T. Tsuyuki, Ellen L. Toth. Evaluating
the role of community pharmacists’ management
in Type 2 Diabetes. Canadian Journal of Diabetes
Care 2001;25(4):266-76. |
|
Scot H. Simpson, Jeffrey A. Johnson, Catherine
Biggs, Rosemarie S. Biggs, Arlene Kuntz, William
Semchuk, Jeff G. Taylor, Farris K, Ross T.
Tsuyuki. Practice-based research: lessons from community
pharmacist participants. Pharmacotherapy 2001;21:731-9. |
|
Carlyn I. Volume, Farris K, Rosemin Kassam,
Cheryl E. Cox, Andrew Cave. Pharmaceutical Care Research
and Education Project (PREP): patient outcomes. Journal
of American Pharmaceutical Association 2001;41:411-420. |
|
Rosemin Kassam, Farris K, Lisa Burback,
Carlyn I. Volume, Cheryl E. Cox, Andrew Cave. Pharmaceutical
Care Research and Education Project (PREP): pharmacists’ interventions. Journal
of American Pharmaceutical Association 2001;41:401-410. |
|
Scot Simpson, Farris K, Jeffrey A. Johnson
J, Ross T. Tsuyuki. Using focus groups to identify
barriers to dug use in patients with congestive heart
failure. Pharmacotherapy 2000;20:823-9. |
|
Carlyn I. Volume, Farris K. Hoping
to maintain a balance: the concept of hope
and the discontinuation of anorexiant medications. Qualitative
Health Research 2000;10:174-87. |
|
| Research Interests |
|
Dr.
Farris' research uses social-psychological theories
with community pharmacy as the context, and she uses
quantitative and qualitative approaches in her research.
Her work contributes to the theoretical and practical
aspects of community pharmacy, ascertaining the social-behavioral
roles of pharmacists and their influences on medication
use. These roles include treatment as well as preventive
roles that community pharmacists may have. For example,
she is studying community pharmacists' preferences
for providing pharmaceutical care (with her graduate
student), evaluating the impact of the Iowa Priority
Brown Bag Review program and exploring models for pharmacists'
to provide brief smoking cessation counseling. A second
and equally important research interest is older adults'
ability to manage their medications. She is exploring
the use of clock-drawing tests and the medication complexity
index as screening tools to predict ability to manage
medications. In addition, she is also quantifying the
impact of the MD.2 Medication Dispensing machine on
patient outcomes. |
|
|
|
| |
|
|
| |
|
|
|
